- Home
- RGNX vs VBNK Comparison
RGNX vs VBNK Comparison
Compare RGNX & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- VBNK
- Stock Information
- Founded
- RGNX 2008
- VBNK 1980
- Country
- RGNX United States
- VBNK Canada
- Employees
- RGNX N/A
- VBNK N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- VBNK Commercial Banks
- Sector
- RGNX Health Care
- VBNK Finance
- Exchange
- RGNX Nasdaq
- VBNK Nasdaq
- Market Cap
- RGNX 387.0M
- VBNK 441.5M
- IPO Year
- RGNX 2015
- VBNK 2021
- Fundamental
- Price
- RGNX $9.49
- VBNK $10.50
- Analyst Decision
- RGNX Strong Buy
- VBNK Strong Buy
- Analyst Count
- RGNX 8
- VBNK 4
- Target Price
- RGNX $31.75
- VBNK $17.50
- AVG Volume (30 Days)
- RGNX 1.3M
- VBNK 48.1K
- Earning Date
- RGNX 07-31-2025
- VBNK 06-04-2025
- Dividend Yield
- RGNX N/A
- VBNK 0.70%
- EPS Growth
- RGNX N/A
- VBNK N/A
- EPS
- RGNX N/A
- VBNK 0.79
- Revenue
- RGNX $156,718,000.00
- VBNK $79,960,487.00
- Revenue This Year
- RGNX $313.52
- VBNK $12.97
- Revenue Next Year
- RGNX N/A
- VBNK $43.72
- P/E Ratio
- RGNX N/A
- VBNK $13.23
- Revenue Growth
- RGNX 80.70
- VBNK N/A
- 52 Week Low
- RGNX $5.04
- VBNK $8.51
- 52 Week High
- RGNX $15.36
- VBNK $18.38
- Technical
- Relative Strength Index (RSI)
- RGNX 49.21
- VBNK 40.75
- Support Level
- RGNX $7.95
- VBNK $10.37
- Resistance Level
- RGNX $11.00
- VBNK $11.83
- Average True Range (ATR)
- RGNX 0.95
- VBNK 0.41
- MACD
- RGNX -0.10
- VBNK -0.15
- Stochastic Oscillator
- RGNX 28.52
- VBNK 13.50
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About VBNK VersaBank
VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.